ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification of phytochemicals in Qingfei Paidu decoction for the treatment of coronavirus disease 2019 by targeting the virus-host interactome

Li, Yuyun; Wu, Yan; Li, Siyan; Li, Yibin; Zhang, Xin; Shou, Zeren; Gu, Shuyin; Zhou, Chenliang; Xu, Daohua; Zhao, Kangni; Tan, Suiyi; Qiu, Jiayin*; Pan, Xiaoyan*; Li, Lin*广东医学院; 广州中医药大学; 南方医科大学
Biomedicine and Pharmacotherapy2022-12DOI: 10.1016/j.biopha.2022.113946
5被引7阅读
引用收藏
分享

摘要

Qingfei Paidu decoction (QFPDD) has been clinically proven to be effective in the treatment of coronavirus disease 2019 (COVID-19). However, the bioactive components and therapeutic mechanisms remain unclear. This study aimed to explore the effective components and underlying mechanisms of QFPDD in the treatment of COVID-19 by targeting the virus-host interactome and verifying the antiviral activities of its active components in vitro. Key active components and targets were identified by analysing the topological features of a compoundtarget-pathway-disease regulatory network of QFPDD for the treatment of COVID-19. The antiviral activity of the active components was determined by a live virus infection assay, and possible mechanisms were analysed by pseudotyped virus infection and molecular docking assays. The inhibitory effects of the components tested on the virus-induced release of IL-6, IL-18 and CXCL-10 were detected by ELISA. Three components of QFPDD, oroxylin A, hesperetin and scutellarin, exhibited potent antiviral activities against live SARS-CoV-2 virus and HCoV-OC43 virus with IC50 values ranging from 18.68 to 63.27 mu M. Oroxylin A inhibited the entry of SARS-CoV-2 pseudovirus into target cells and inhibited SARS-CoV-2 S protein-mediated cell-cell fusion by binding with the ACE2 receptor. The active components of QFPDD obviously inhibited the IL-6, IL-18 and CXCL-10 release induced by the SARS-CoV-2 S protein. This study supports the clinical application of QFPDD and provides an effective analysis method for the in-depth study of the mechanisms of traditional Chinese medicine (TCM) in the prevention and treatment of COVID-19.

学科与关键词

关键词
COVID-19Qingfei Paidu DecoctionSARS-CoV-2BioinformaticsSystematic pharmacologyVirus -host interactome
相关
加载中…
  • Broad antiviral and anti-inflammatory activity of Qingwenjiere mixture against SARS-CoV-2 and other human coronavirus infections
    Xie, Peifang; Fang, Yue; Shen, Zhili; Shao, Yulan; Ma, Qinhai; Yang, Zifeng; Zhao, Jincun; Li, Hongmei; Li, Rongtao; Dong, Shuwei*; Wen, Weibo*; Xia, Xueshan*PHYTOMEDICINE, 2021, 93: 153808.被引 9
  • Exploration of the Mechanism of Lianhua Qingwen in Treating Influenza Virus Pneumonia and New Coronavirus Pneumonia with the Concept of "Different Diseases with the Same Treatment" Based on Network Pharmacology
    Su, Huihui*; Wu, Guosong; Zhan, Lulu; Xu, Fei; Qian, Huiqin; Li, Yanling; Zhu, Ximei*Evidence-based Complementary and Alternative Medicine, 2022, 2022: 5536266.被引 7
  • Exploring the Potential Targets and Mechanisms of Huang Lian Jie Du Decoction in the Treatment of Coronavirus Disease 2019 Based on Network Pharmacology
    Liu, Wang; Zeng, Yu; Li, Yanda; Li, Nanhong; Peng, Min; Cheng, Junfen; Tian, Binbin*; Chen, Mingdi*International Journal of General Medicine, 2021, 14: 9873-9885.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
Biomedicine and Pharmacotherapy
发表日期
2022-12
卷期
第 156 卷
页码
113946
DOI
10.1016/j.biopha.2022.113946
语言
MULTI-LANGUAGE
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82273976, 82073896, 82072276]; Natural Science Foundation of Guangdong Province [2018B030312010]; Guangdong Basic and Applied Basic Research Foundation [2019A1515010061, 2021A1515011096]; Construction Project of Influenza Prevention and Treatment Technology System of Chinese Medicine [ZZ13 - 035 - 02]; Guangzhou Science and Technology Basic and Applied Basic Research Foundation [202102080108]; China Postdoctoral Science Foundation [2020M681947]

作者

  • L

    Li, Yuyun (第一作者)

    guangdong med univ · new · southern med univ

  • W

    Wu, Yan

    chinese acad sci, wuhan inst virol

查看全部 14 位作者收起作者
  • L

    Li, Siyan

    guangzhou univ chinese med

  • L

    Li, Yibin

    new · southern med univ

  • Z

    Zhang, Xin

    new · southern med univ

  • S

    Shou, Zeren

    new · southern med univ

  • G

    Gu, Shuyin

    new · southern med univ

  • Z

    Zhou, Chenliang

    new · southern med univ

  • X

    Xu, Daohua

    guangdong med univ · new

  • Z

    Zhao, Kangni

    new · southern med univ

  • T

    Tan, Suiyi

    new · southern med univ

  • Q

    Qiu, Jiayin (通讯)

    zhejiang chinese med univ

  • P

    Pan, Xiaoyan (通讯)

    chinese acad sci, wuhan inst virol

  • L

    Li, Lin (通讯)

    new · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417